John Valliere‐Douglass

Author

Also Known As

J. F Valliere-Douglass, John F. Valliere-Douglass, John F. Valliere‐Douglass, John Valliere-Douglass, John Valliere‐Douglass

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)Seagen (United States)Fred Hutch Cancer Center

About

John Valliere‐Douglass is an author at Amgen (United States) specializing in medicine, antibody engineering, and mass spectrometry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	977
2	Natural Sciences	11	11	724
3	Biochemistry	9	9	546
4	Engineering	3	3	169
5	Allergy	2	2	100

John Valliere‐Douglass

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain Boxu Yan, Sean Steen, David M. Hambly, Journal of Pharmaceutical Sciences Succinimide FormationAsn 55Immunocytochemical TechniqueNatural SciencesImmunology	2009	168
Native Intact Mass Determination of Antibodies Conjugated with Monomethyl Auristatin E and F at Interchain Cysteine Residues John Valliere‐Douglass, William A. McFee, Oscar Salas‐Solano Analytical Chemistry Immunocytochemical TechniqueInterchain Cysteine ResiduesMonomethyl Auristatin EIntact MassBioanalysis	2012	142
Resolving Disulfide Structural Isoforms of IgG2 Monoclonal Antibodies by Ion Mobility Mass Spectrometry Dhanashri Bagal, John Valliere‐Douglass, Alain Balland, Analytical Chemistry	2010	101
Analysis of post-translational modifications in recombinant monoclonal antibody IgG1 by reversed-phase liquid chromatography/mass spectrometry Boxu Yan, John Valliere‐Douglass, Lowell J. Brady, Journal of Chromatography A Post-translational ModificationsBioanalysisMass SpectrometryBiological Mass SpectrometryImmunology	2007	100
Characterization of SGN-CD123A, A Potent CD123-Directed Antibody–Drug Conjugate for Acute Myeloid Leukemia Fu Li, May Kung Sutherland, Changpu Yu, Molecular Cancer Therapeutics	2017	94
Glutamine-linked and Non-consensus Asparagine-linked Oligosaccharides Present in Human Recombinant Antibodies Define Novel Protein Glycosylation Motifs John Valliere‐Douglass, Catherine M. Eakin, Alison Wallace, Journal of Biological Chemistry	2010	86
Conformation and Dynamics of Interchain Cysteine-Linked Antibody-Drug Conjugates as Revealed by Hydrogen/Deuterium Exchange Mass Spectrometry Lucy Pan, Oscar Salas‐Solano, John Valliere‐Douglass Analytical Chemistry Adcs RelativeMolecular BiologyPeptide ScienceAnalytical UltracentrifugationChemical Biology	2014	86
Separation of populations of antibody variants by fine tuning of hydrophobic-interaction chromatography operating conditions John Valliere‐Douglass, Alison Wallace, Alain Balland Journal of Chromatography A ImmunohematologyEngineeringMedicineBioanalysisImmunology	2008	83
Measurement of <i>in Vivo</i> Drug Load Distribution of Cysteine-Linked Antibody–Drug Conjugates Using Microscale Liquid Chromatography Mass Spectrometry Shawna Hengel, Russell J. Sanderson, John Valliere‐Douglass, Analytical Chemistry Drug TargetEngineeringImmunocytochemical TechniqueBiological Mass SpectrometryDrug-load Distribution	2014	70
Molecular mass analysis of antibodies by on-line SEC-MS Lowell J. Brady, John Valliere‐Douglass, Theresa Martinez, Journal of the American Society for Mass Spectrometry ImmunologyBiological Mass SpectrometryGlycobiologyMolecular BiologyMass Analysis	2008	68

Page 1